Tackling deadly newborn disease, BridgeBio affiliate wins FDA drug approval

The BridgeBio model is designed to move drugs tackling rare diseases with a well-defined genetic basis quickly and efficiently to approval.

Source: bizjournals.com Health Care:Physician Practices headlines - February 26, 2021 Category: American Health Authors: Ron Leuty Source Type: news